Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2020
Intellia announces pricing of public stock offering
Intellia Therapeutics announced pricing for an underwritten public offering of 4,794,521 common shares at $36.50 per share and granted the underwriters a 30-day option to buy additional shares.
2020
Intellia reports fourth-quarter and full-year 2019 results
Intellia Therapeutics reported operational highlights and financial results for the fourth quarter and year ended December 31, 2019.